新方法实现在存档组织样本中探索单一细胞，拓展转译与临床研究的实现途径 西雅图--(美国商业资讯)--领先的可扩展且易使用的单细胞定序解决方案供应商Parse Biosciences于今日宣布一项突破性技术，该技术能全面释放福尔马林固定石蜡包埋（FFPE）样本的潜能。

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Dec 14, 2023 at 5:00 ...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing ...

Acquisition strengthens QIAGEN’s presence in the rapidly growing single-cell market, accelerating growth across its industry-leading Sample technologies portfolio Parse provides Evercode, a highly ...

Parse Biosciences today announced a $7 million investment round to support growth of its single cell sequencing technology. The biotech startup sells a “Whole Transcriptome Kit” that can profile up to ...

Collaboration pairs robust synthetic biology platform with massive scale single cell sequencing to overcome long-standing challenges in variant mapping SEATTLE, December 19, 2025--(BUSINESS ...

SEATTLE, February 19, 2025--(BUSINESS WIRE)--Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single ...

Parse Biosciences is a fast-growing innovator in single-cell sample preparation, with technologies used in more than 3,000 labs across over 40 countries Acquisition strengthens QIAGEN’s presence in ...